A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Linda Duska, MD
University of Virginia School of Medicine
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Maine Medical Center (mmp Women'S Health)
Scarborough, Maine, United States
- Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, United States
- Duke University
Durham, North Carolina, United States
- Stephenson Cancer Center University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States
- Md Anderson
Houston, Texas, United States
- University of Virginia
Charlottesville, Virginia, United States
- Virginia Commonwealth University
Richmond, Virginia, United States
- University of Wisconsin-Madison
Madison, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Sept 2012
- Primary completion
- 1 Jun 2018
- Completion
- 31 Dec 2020
- Last update posted
- 25 Feb 2021
- Registered enrollment
- 148
- Registry id
- NCT01610206
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.